SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ: SQNM), a leading provider of fine mapping genotyping, methylation and gene expression analysis solutions, today announced the commercial launch of its MassARRAY® TYPER 4.0 genotyping software. TYPER 4.0 significantly enhances data quality, simplifies workflow, and improves ease of use. The software is used in conjunction with Sequenom’s iPLEX™ Gold assay, a multiplexing assay that runs on Sequenom’s proprietary MassARRAY System for fine mapping genotyping applications including studies validating the association of single nucleotide polymorphisms (SNPs) with specific diseases.
